Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants

Por Baxter, Roger, Keshavan, Pavitra, Welsch, Jo Anne, Han, Linda, Smolenov, Igor
Publicado no Hum Vaccin Immunother (2016)

A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months

Por Carmona Martinez, Alfonso, Salamanca de la Cueva, Ignacio, Boutet, Philippe, Vanden Abeele, Carline, Smolenov, Igor, Devaster, Jeanne-Marie
Publicado em 2014

Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents

Por Saez-Llorens, Xavier, Aguilera Vaca, Diana Catalina, Abarca, Katia, Maho, Emmanuelle, Graña, Maria Gabriela, Heijnen, Esther, Smolenov, Igor, Dull, Peter M
Publicado no Hum Vaccin Immunother (2015)